Literature DB >> 7053625

The decreasing incidence of endometrial cancer: public health implications.

D F Austin, K M Roe.   

Abstract

The incidence of endometrial cancer in the San Francisco area between 1969 and 1979 is compared to trends in estrogen sales and prescriptions. Both estrogen use and endometrial cancer incidence increased steadily until 1975 and then decreased significantly. The data support the previously documented association between endometrial cancer and estrogen use, but suggest that short-term usage may carry only slightly increased risk which can be eliminating entirely upon termination of therapy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7053625      PMCID: PMC1649756          DOI: 10.2105/ajph.72.1.65

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  13 in total

1.  Estrogens and endometrial cancer in a retirement community.

Authors:  T M Mack; M C Pike; B E Henderson; R I Pfeffer; V R Gerkins; M Arthur; S E Brown
Journal:  N Engl J Med       Date:  1976-06-03       Impact factor: 91.245

2.  Increased risk of endometrial carcinoma among users of conjugated estrogens.

Authors:  H K Ziel; W D Finkle
Journal:  N Engl J Med       Date:  1975-12-04       Impact factor: 91.245

3.  Increasing incidence of endometrial cancer in the United States.

Authors:  N S Weiss; D R Szekely; D F Austin
Journal:  N Engl J Med       Date:  1976-06-03       Impact factor: 91.245

4.  Estrogen and endometrial cancer: cases and two control groups from North Carolina.

Authors:  B S Hulka; W C Fowler; D G Kaufman; R C Grimson; B G Greenberg; C J Hogue; G S Berger; C C Pulliam
Journal:  Am J Obstet Gynecol       Date:  1980-05-01       Impact factor: 8.661

5.  Replacement estrogens and endometrial cancer.

Authors:  H Jick; R N Watkins; J R Hunter; B J Dinan; S Madsen; K J Rothman; A M Walker
Journal:  N Engl J Med       Date:  1979-02-01       Impact factor: 91.245

6.  Declining rates of endometrial cancer.

Authors:  A M Walker; H Jick
Journal:  Obstet Gynecol       Date:  1980-12       Impact factor: 7.661

7.  Estrogens and endometrial carcinoma.

Authors:  L A Gray; W M Christopherson; R N Hoover
Journal:  Obstet Gynecol       Date:  1977-04       Impact factor: 7.661

8.  Effects of long-term estrogen replacement therapy. I. Metabolic effects.

Authors:  C B Hammond; F R Jelovsek; K L Lee; W T Creasman; R T Parker
Journal:  Am J Obstet Gynecol       Date:  1979-03-01       Impact factor: 8.661

9.  Endometrial cancer in relation to patterns of menopausal estrogen use.

Authors:  N S Weiss; D R Szekely; D R English; A I Schweid
Journal:  JAMA       Date:  1979-07-20       Impact factor: 56.272

10.  Risk of exogenous estrogen therapy and endometrial cancer.

Authors:  F R Jelovsek; C B Hammond; B H Woodard; R Draffin; K L Lee; W T Creasman; R T Parker
Journal:  Am J Obstet Gynecol       Date:  1980-05-01       Impact factor: 8.661

View more
  8 in total

Review 1.  Organochlorine compounds and estrogen-related cancers in women.

Authors:  H O Adami; L Lipworth; L Titus-Ernstoff; C C Hsieh; A Hanberg; U Ahlborg; J Baron; D Trichopoulos
Journal:  Cancer Causes Control       Date:  1995-11       Impact factor: 2.506

2.  Prescribing estrogen during menopause: physician survey of practices in 1974 and 1981.

Authors:  B H Pasley; S J Standfast; S H Katz
Journal:  Public Health Rep       Date:  1984 Jul-Aug       Impact factor: 2.792

3.  Endometrial cancer in Puerto Rico: incidence, mortality and survival (1992-2003).

Authors:  Ana Patricia Ortiz; Javier Pérez; Yomayra Otero-Domínguez; Omar García-Rodríguez; Sheyla Garced-Tirado; Frances Escalera-Maldonado; Sadja Gaud-Quintana; Elvis Santiago-Rodríguez; Katherine Svensson; José L Vergara-Arroyo; Karen Ortiz; Mariela Torres; Guillermo Tortolero-Luna; Nayda Figueroa-Vallés
Journal:  BMC Cancer       Date:  2010-02-03       Impact factor: 4.430

4.  Recent declines in breast cancer incidence: mounting evidence that reduced use of menopausal hormones is largely responsible.

Authors:  Emily Banks; Karen Canfell
Journal:  Breast Cancer Res       Date:  2010-02-12       Impact factor: 6.466

5.  Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin.

Authors:  Graham A Colditz
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

Review 6.  Estrogen replacement therapy (ERT) in high-risk cancer patients.

Authors:  K A Hutchinson-Williams; J N Gutmann
Journal:  Yale J Biol Med       Date:  1991 Nov-Dec

7.  Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control.

Authors:  Ahmedin Jemal; Michael J Thun; Lynn A G Ries; Holly L Howe; Hannah K Weir; Melissa M Center; Elizabeth Ward; Xiao-Cheng Wu; Christie Eheman; Robert Anderson; Umed A Ajani; Betsy Kohler; Brenda K Edwards
Journal:  J Natl Cancer Inst       Date:  2008-11-25       Impact factor: 13.506

Review 8.  Chemical carcinogens: a review of the science and its associated principles. U.S. Interagency Staff Group on Carcinogens.

Authors: 
Journal:  Environ Health Perspect       Date:  1986-08       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.